期刊文献+

预测前列腺癌根治术后生化复发的研究 被引量:7

Study on the Prediction of Biochemical Recurrence After Radical Prostatectomy
下载PDF
导出
摘要 前列腺癌患者在行根治性治疗后复发率较高,多数患者会出现生化复发(BCR)。生化复发是提示前列腺癌根治术后复发的重要指标之一,前列腺癌患者根治术后生化复发的预测是目前研究热点。本文就BCR的定义及术前血清前列腺特异抗原水平(PSA)、肿瘤体积、Gleason评分、手术切缘、精囊侵犯、淋巴血管侵犯及手术方式等危险因素在预测前列腺癌患者根治术后生化复发方面的研究作一综述,以期为临床防治BCR提供参考。 Prostate cancer patients have a higher recurrence rate after radical treatment,and most patients will have biochemical recurrence(BCR).Biochemical recurrence is one of the important indicators for the recurrence of prostate cancer after radical resection.The prediction of biochemical recurrence after radical resection of prostate cancer is the current research hotspot.This article focuses on the definition of BCR and preoperative serum prostate-specific antigen levels(PSA),tumor volume,Gleason score,surgical margin,seminal vesicle invasion,lymphatic vessel invasion,and surgical methods in predicting biochemical recurrence in patients with prostate cancer to make a review of the research,it is expected to provide reference for clinical prevention and treatment of BCR.
作者 陈彦君 刘建萍 龚志勇 CHEN Yan-jun;LIU Jian-ping;GONG Zhi-yong(Department of Urology,Affiliated Hospital of North Sichuan Medical College,Nanchong 637000,Sichuan,China)
出处 《医学信息》 2021年第5期49-53,共5页 Journal of Medical Information
关键词 前列腺癌 前列腺癌根治术 生化复发 PSA Prostate cancer Radical prostatectomy Biochemical recurrence PSA
  • 相关文献

参考文献5

二级参考文献54

  • 1Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
  • 2Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, et al. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013; 45: 1-14.
  • 3Hong J H, Kim IY. Nonmetastatic castration-resistant prostate cancer. Korean JUral 2014; 55: 153-60.
  • 4Cooperberg MR, Broering JM, Carroll PRo Time trends and local variation in primary treatment of localized prostate cancer. J Clin Onco12010; 28: 1117-23.
  • 5Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 203-13.
  • 6Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. JUral 2011; 185: 869-75.
  • 7D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74.
  • 8Zumsteg ZS, Spratt DE, Pei I, Zhang Z, Yamada Y, et al. A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy. Eur Urol 2013; 64: 895-902.
  • 9Reese AC, Pierorazio PM, Han M, Partin AW. Contemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification system. Urology 2012; 80: 1075-9.
  • 10Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, et al. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies, results from CaPSURE. Uralogy2002; 59, 560-5.

共引文献37

同被引文献66

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部